Prasanna; Ganesh

Patent Applications and Registrations

Patent applications and USPTO patent grants for Prasanna; Ganesh.The latest application filed is for "indane and indoline derivatives and the use thereof as soluble guanylate cyclase activators".

Company Profile

2.10.14

Prasanna; Ganesh - Acton MA
Prasanna; Ganesh - Fort Worth TX
Prasanna; Ganesh - San Diego CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Indane and indoline derivatives and the use thereof as soluble guanylate cyclase activators Grant 10,550,102 - Adams , et al. Fe	2020-02-04
Indane And Indoline Derivatives And The Use Thereof As Soluble Guanylate Cyclase Activators App 20190119254 - ADAMS; Christopher M. ; et al.	2019-04-25
Indane and indoline derivatives and the use thereof as soluble guanylate cyclase activators Grant 10,208,018 - Adams , et al. Feb	2019-02-19
Cyclohexen-1-yl-pyridin-2-yl-1h-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activators Grant 9,957,254 - Adams , et al. May 1, 2	2018-05-01
Thiophen-2-yl-pyridin-2-yl-1H-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activators Grant 9,765,067 - Adams , et al. September 19, 2	2017-09-19
Indane And Indoline Derivatives And The Use Thereof As Soluble Guanylate Cyclase Activators App 20170197940 - ADAMS; Christopher M. ; et al.	2017-07-13
Cyclohexen-1-yl-pyridin-2-yl-1h-pyrazole-4-carboxylic Acid Derivatives And The Use Thereof As Soluble Guanylate Cyclase Activators App 20170197941 - ADAMS; Christopher M. ; et al.	2017-07-13
Thiophen-2-yl-pyridin-2-yl-1h-pyrazole-4-carboxylic Acid Derivatives And The Use Thereof As Soluble Guanylate Cyclase Activators App 20170197950 - ADAMS; Christopher M. ; et al.	2017-07-13
Bradykinin Receptor Agonists And Uses Thereof To Treat Ocular Hypertension And Glaucoma App 20120283260 - Combrink; Keith D. ; et al.	2012-11-08
Bradykinin receptor agonists and uses thereof to treat ocular hypertension and glaucoma Grant 8,252,793 - Combrink , et al. August 28, 2	2012-08-28
Bradykinin Receptor Agonists And Uses Thereof To Treat Ocular Hypertension And Glaucoma App 20120046285 - Combrink; Keith D. ; et al.	2012-02-23
Nitric oxide donating prostamides Grant 8,101,658 - Benedini , et al. January 24, 2	2012-01-24
Nitric Oxide Donating Prostamides App 20110092590 - Benedini; Francesca ; et al.	2011-04-21
EP2 Agonists App 20100105905 - Prasanna; Ganesh ; et al.	2010-04-29
EP2 agonists Grant 7,622,475 - Prasanna , et al. November 24, 2	2009-11-24
Ep2 Agonists App 20080045545 - Prasanna; Ganesh ; et al.	2008-02-21
Phenanthroline and derivatives thereof used to lower intraocular pressure in an affected eye App 20060111388 - Dibas; Adnan ; et al.	2006-05-25
Endothelin antagonists and endothelin-converting enzyme inhibitors for the treatment of glaucoma App 20030176356 - Yorio, Thomas ; et al.	2003-09-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.